The April 2025 CJEU ruling: the day 2,000 botanical health claims became illegal in the EU

Can we actually reverse aging? Scientists just put it to the test in humans.

This week, the first patient was dosed in a landmark trial of ER-100, the first cellular reprogramming therapy to reach people. We unpack the science behind "making cells young again": how three Yamanaka transcription factors reset the epigenetic clock without touching your DNA, why dropping the cancer-linked one matters, and the clever doxycycline "off-switch" that makes it safe enough for the clinic. Then the practical aspects. Gene therapy is reversal in the clinic, but what about the rest population? We dig into where natural bioactives fit for everyday prevention, why ingredient synergy beats single molecules, and how AI is bringing personalized formulations to longevity. Publications of interest: World-first: therapy to make cells young again trialled in a person [https://www.nature.com/articles/d41586-026-01836-7]  https://www.lifebiosciences.com/life-biosciences-announces-first-patient-dosed-in-phase-1-trial-of-er-100-for-optic-neuropathies/ [https://]  https://clinicaltrials.gov/study/NCT07290244 [https://]  https://www.technologynetworks.com/biopharma/articles/re-setting-the-epigenetic-clock-to-reverse-cellular-aging-413392

Commodity ingredient prices tell you nothing about the value of the science inside

Curcumin: $3-34/kg commodity, $60-600/kg branded. Astaxanthin: $2,500/kg synthetic (aquaculture), $7,000+/kg natural (supplement). Saffron stigma: $5,000-10,000/kg raw, $0.30/dose clinical. Ginseng root: $50-200/kg standard, $10,000-50,000/kg wild. The spread between commodity price and branded price is entirely a function of scientific understanding: mechanism and patent and clinical evidence and brand = 5-20x premium. Publications of interest: https://pmc.ncbi.nlm.nih.gov/articles/PMC10061533/ https://pmc.ncbi.nlm.nih.gov/articles/PMC6806606/ https://pmc.ncbi.nlm.nih.gov/articles/PMC9654660/

The April 2025 CJEU ruling: the day 2,000 botanical health claims became illegal in the EU

The CJEU ruled that generic botanical health claims (the "on-hold" list) are prohibited until EFSA evaluation is complete, a process frozen since 2010. This affects every botanical ingredient company selling in the EU. But Article 13.5 allows proprietary claims based on your own clinical evidence. The ruling didn't just block generic claims, it eliminated generic competition. For companies with mechanism data and patents, this is the most advantageous regulatory environment in EU nutraceutical history. Publications of interest: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex:62023CJ0386, https://pmc.ncbi.nlm.nih.gov/articles/PMC11879797/

Amaranth: The only grain with meaningful nitrate content for sports performance

Amaranth leaves contain high levels of inorganic nitrate, the same compound found in beetroot that converts to nitric oxide for vasodilation and athletic performance. But unlike beetroot (a root vegetable), amaranth is a complete protein source AND a nitrate source. Arjuna Natural's Oxystorm positions amaranth leaf extract as a nitric oxide ingredient, an entirely different market than "ancient grain." Publications of interest: https://pmc.ncbi.nlm.nih.gov/articles/PMC7359009/ https://pubmed.ncbi.nlm.nih.gov/27131407/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5969023/

Andrographis: The 'King of Bitters' that Thailand used as a COVID treatment

In 2021, Thailand's Department of Thai Traditional and Alternative Medicine approved andrographis (Fah Talai Jone) for early-stage COVID-19 treatment. Andrographolide covalently binds to the p50 subunit of NF-kB one of the most specific and irreversible anti-inflammatory mechanisms known in natural products. This isn't weak binding or allosteric modulation. It's a covalent modification. That's drug-level mechanism specificity in a plant extract that costs pennies. Publications of interest: https://pubmed.ncbi.nlm.nih.gov/15356172/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11246112/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12351123/